Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90


Novel breast cancer risk alleles and endometrial cancer risk.

McGrath M, Lee IM, Buring J, Hunter DJ, De Vivo I.

Int J Cancer. 2008 Dec 15;123(12):2961-4. doi: 10.1002/ijc.23862.


Genetic variation in CYP11A1 and StAR in relation to endometrial cancer risk.

Terry K, McGrath M, Lee IM, Buring J, De Vivo I.

Gynecol Oncol. 2010 May;117(2):255-9. doi: 10.1016/j.ygyno.2010.02.002. Epub 2010 Mar 2.


Common genetic variation within IGFI, IGFII, IGFBP-1, and IGFBP-3 and endometrial cancer risk.

McGrath M, Lee IM, Buring J, De Vivo I.

Gynecol Oncol. 2011 Feb;120(2):174-8. doi: 10.1016/j.ygyno.2010.10.012.


Breast cancer susceptibility associated with rs1219648 (fibroblast growth factor receptor 2) and postmenopausal hormone therapy use in a population-based United States study.

Andersen SW, Trentham-Dietz A, Figueroa JD, Titus LJ, Cai Q, Long J, Hampton JM, Egan KM, Newcomb PA.

Menopause. 2013 Mar;20(3):354-8. doi: 10.1097/GME.0b013e318268ca46.


Genetic variants in FGFR2 and MAP3K1 are associated with the risk of familial and early-onset breast cancer in a South-American population.

Jara L, Gonzalez-Hormazabal P, Cerceño K, Di Capua GA, Reyes JM, Blanco R, Bravo T, Peralta O, Gomez F, Waugh E, Margarit S, Ibañez G, Romero C, Pakomio J, Roizen G.

Breast Cancer Res Treat. 2013 Jan;137(2):559-69. doi: 10.1007/s10549-012-2359-z. Epub 2012 Dec 7.


Breast cancer susceptibility alleles and ovarian cancer risk in 2 study populations.

Gates MA, Tworoger SS, Terry KL, De Vivo I, Hunter DJ, Hankinson SE, Cramer DW.

Int J Cancer. 2009 Feb 1;124(3):729-33. doi: 10.1002/ijc.23924.


Association of common genetic variants with breast cancer risk and clinicopathological characteristics in a Chinese population.

Chan M, Ji SM, Liaw CS, Yap YS, Law HY, Yoon CS, Wong CY, Yong WS, Wong NS, Ng R, Ong KW, Madhukumar P, Oey CL, Tan PH, Li HH, Ang P, Ho GH, Lee AS.

Breast Cancer Res Treat. 2012 Nov;136(1):209-20. doi: 10.1007/s10549-012-2234-y. Epub 2012 Sep 11.


HSD17B1 gene polymorphisms and risk of endometrial and breast cancer.

Setiawan VW, Hankinson SE, Colditz GA, Hunter DJ, De Vivo I.

Cancer Epidemiol Biomarkers Prev. 2004 Feb;13(2):213-9.


+331G/A variant in the progesterone receptor gene, postmenopausal hormone use and risk of breast cancer.

Kotsopoulos J, Tworoger SS, De Vivo I, Hankinson SE, Hunter DJ, Willett WC, Chen WY.

Int J Cancer. 2009 Oct 1;125(7):1685-91. doi: 10.1002/ijc.24477. Erratum in: Int J Cancer. 2009 Nov 15;125(10):2487. DeVivo, Immaculata [corrected to De Vivo, Immaculata].


Association of a single nucleotide polymorphism at 6q25.1,rs2046210, with endometrial cancer risk among Chinese women.

Li G, Xiang YB, Courtney R, Cheng JR, Huang B, Long JR, Cai H, Zheng W, Shu XO, Cai Q.

Chin J Cancer. 2011 Feb;30(2):138-43.


Progesterone receptor gene variants and risk of endometrial cancer.

O'Mara TA, Fahey P, Ferguson K, Marquart L, Lambrechts D, Despierre E, Vergote I, Amant F, Hall P, Liu J, Czene K; SASBAC, Rebbeck TR; WISE Study Group; AOCS Management Group; SEARCH, Ahmed S, Dunning AM, Gregory CS, Shah M; ANECS, Webb PM, Spurdle AB.

Carcinogenesis. 2011 Mar;32(3):331-5. doi: 10.1093/carcin/bgq263. Epub 2010 Dec 10.


Single nucleotide polymorphisms associated with risk for contralateral breast cancer in the Women's Environment, Cancer, and Radiation Epidemiology (WECARE) Study.

Teraoka SN, Bernstein JL, Reiner AS, Haile RW, Bernstein L, Lynch CF, Malone KE, Stovall M, Capanu M, Liang X, Smith SA, Mychaleckyj J, Hou X, Mellemkjaer L, Boice JD Jr, Siniard A, Duggan D, Thomas DC; WECARE Study Collaborative Group, Concannon P.

Breast Cancer Res. 2011;13(6):R114. doi: 10.1186/bcr3057. Epub 2011 Nov 17.


Polymorphisms in genes hydroxysteroid-dehydrogenase-17b type 2 and type 4 and endometrial cancer risk.

Karageorgi S, McGrath M, Lee IM, Buring J, Kraft P, De Vivo I.

Gynecol Oncol. 2011 Apr;121(1):54-8. doi: 10.1016/j.ygyno.2010.11.014. Epub 2010 Dec 3.


Common genetic variants associated with breast cancer in Korean women and differential susceptibility according to intrinsic subtype.

Han W, Woo JH, Yu JH, Lee MJ, Moon HG, Kang D, Noh DY.

Cancer Epidemiol Biomarkers Prev. 2011 May;20(5):793-8. doi: 10.1158/1055-9965.EPI-10-1282. Epub 2011 Mar 17.


Two estrogen-related variants in CYP19A1 and endometrial cancer risk: a pooled analysis in the Epidemiology of Endometrial Cancer Consortium.

Setiawan VW, Doherty JA, Shu XO, Akbari MR, Chen C, De Vivo I, Demichele A, Garcia-Closas M, Goodman MT, Haiman CA, Hankinson SE, Henderson BE, Horn-Ross PL, Lacey JV Jr, Le Marchand L, Levine DA, Liang X, Lissowska J, Lurie G, McGrath M, Narod SA, Rebbeck TR, Ursin G, Weiss NS, Xiang YB, Yang HP, Zheng W, Olson SH.

Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):242-7. doi: 10.1158/1055-9965.EPI-08-0689.


Genetic variations in UGT1A1 and UGT2B7 and endometrial cancer risk.

McGrath M, Lepine J, Lee IM, Villeneuve L, Buring J, Guillemette C, De Vivo I.

Pharmacogenet Genomics. 2009 Mar;19(3):239-43. doi: 10.1097/FPC.0b013e328323f66c.


Polymorphisms and haplotypes in the caspase-3, caspase-7, and caspase-8 genes and risk for endometrial cancer: a population-based, case-control study in a Chinese population.

Xu HL, Xu WH, Cai Q, Feng M, Long J, Zheng W, Xiang YB, Shu XO.

Cancer Epidemiol Biomarkers Prev. 2009 Jul;18(7):2114-22. doi: 10.1158/1055-9965.EPI-09-0152. Epub 2009 Jun 16.


Genome-Wide Association Studies (GWAS) breast cancer susceptibility loci in Arabs: susceptibility and prognostic implications in Tunisians.

Shan J, Mahfoudh W, Dsouza SP, Hassen E, Bouaouina N, Abdelhak S, Benhadjayed A, Memmi H, Mathew RA, Aigha II, Gabbouj S, Remadi Y, Chouchane L.

Breast Cancer Res Treat. 2012 Oct;135(3):715-24. doi: 10.1007/s10549-012-2202-6. Epub 2012 Aug 22.


Replication of five GWAS-identified loci and breast cancer risk among Hispanic and non-Hispanic white women living in the Southwestern United States.

Slattery ML, Baumgartner KB, Giuliano AR, Byers T, Herrick JS, Wolff RK.

Breast Cancer Res Treat. 2011 Sep;129(2):531-9. doi: 10.1007/s10549-011-1498-y. Epub 2011 Apr 8.


Genetic predisposition, parity, age at first childbirth and risk for breast cancer.

Butt S, Harlid S, Borgquist S, Ivarsson M, Landberg G, Dillner J, Carlson J, Manjer J.

BMC Res Notes. 2012 Aug 7;5:414. doi: 10.1186/1756-0500-5-414.

Supplemental Content

Support Center